CC
Crosslink Capital’s Cellebrite CLBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Sell |
696,744
-1,532,495
| -69% | -$24.5M | 0.63% | 20 |
|
|
2025
Q1 | $43.3M | Sell |
2,229,239
-792,951
| -26% | -$15.4M | 6.74% | 6 |
|
|
2024
Q4 | $66.6M | Sell |
3,022,190
-464,755
| -13% | -$10.2M | 9.26% | 3 |
|
|
2024
Q3 | $58.7M | Sell |
3,486,945
-99,480
| -3% | -$1.68M | 7.89% | 3 |
|
|
2024
Q2 | $42.9M | Sell |
3,586,425
-8,632
| -0.2% | -$103K | 5.98% | 7 |
|
|
2024
Q1 | $39.8M | Buy |
3,595,057
+354,577
| +11% | +$3.93M | 5.67% | 9 |
|
|
2023
Q4 | $28.1M | Buy |
3,240,480
+44,520
| +1% | +$386K | 4.17% | 11 |
|
|
2023
Q3 | $24.4M | Sell |
3,195,960
-11,809
| -0.4% | -$90.3K | 4.61% | 10 |
|
|
2023
Q2 | $23.1M | Buy |
3,207,769
+194,194
| +6% | +$1.4M | 3.82% | 12 |
|
|
2023
Q1 | $18.4M | Buy |
3,013,575
+9,923
| +0.3% | +$60.4K | 3.73% | 14 |
|
|
2022
Q4 | $13.1M | Buy |
3,003,652
+119,001
| +4% | +$519K | 3.16% | 16 |
|
|
2022
Q3 | $11.3M | Buy |
2,884,651
+682,312
| +31% | +$2.67M | 2.89% | 13 |
|
|
2022
Q2 | $11.2M | Buy |
2,202,339
+68,612
| +3% | +$350K | 3.25% | 14 |
|
|
2022
Q1 | $13.7M | Buy |
2,133,727
+116,105
| +6% | +$743K | 2.57% | 15 |
|
|
2021
Q4 | $16.2M | Sell |
2,017,622
-188,220
| -9% | -$1.51M | 2.56% | 13 |
|
|
2021
Q3 | $20.4M | Buy |
+2,205,842
| New | +$20.4M | 3.69% | 10 |
|